T he multifunctional Ca 2ϩ and calmodulin dependent protein kinase (CaMK)II is a serine threonine kinase that plays increasingly evident and important roles in regulating ion channels in heart and other excitable tissues. CaMKII activation initially requires an increase in intracellular Ca 2ϩ that leads to binding of calcified calmodulin (Ca 2ϩ /CaM) to the CaMKII regulatory domain. This activating Ca 2ϩ /CaM signal is amplified within the CaMKII holoenzyme, which is composed of 10 to 12 monomers arranged in a wheel and spoke pattern ( Figure, A) , by an autophosphorylation process. Autophosphorylation of Thr286/287 (numbering varies by isoform) markedly increases the avidity of Ca 2ϩ /CaM binding to CaMKII but also renders CaMKII constitutively active even in the absence of Ca 2ϩ /CaM binding. 1 Autophosphorylation of Thr286/287 prevents the reassociation of the autoinhibitory region with the CaMKII catalytic domain, leaving the autophosphorylated kinase in the open and active configuration. Reactive oxygen species modify a pair of methionines (281/282) near the autophosphorylation site to convert CaMKII activity from Ca 2ϩ /CaM-dependent to Ca 2ϩ /CaMindependent by a process that mirrors autophosphorylation (Figure, A) . 2 In this issue of Circulation Research, El-Haou et al 3 have provided exciting new insights into the association of CaMKII with the MAGUK protein SAP97 by showing that a PDZ motif on the C terminus of K V 4.3 partners with the SAP97-CaMKII module to enable CaMKII-dependent gating effects on K V 4.3 channels. CaMKII-mediated increases in the transient outward current (I to ) require binding of the SAP97-CaMKII module to the K V 4.3 C terminus. These findings provide a molecular framework for understanding how excitable tissues tune repolarization to manage cellular Ca 2ϩ entry.
Connecting Cellular Ca

2؉
With Repolarization
The cardiac action potential is long (even in the atrium) compared to action potentials in other excitable tissues, and the action potential repolarization duration 4 and configuration 5 . CaMKII increases I to to shorten the action potential duration and narrow the membrane potential window permissive for I Ca . Thus, CaMKII activity at K V 4.3 appears to balance the membrane potential and shorten the action potential to oppose the irrational exuberance of excessive CaMKII-mediated I Ca increases (Figure, B), at least in healthy myocardium. CaMKII activity supports key physiological tasks in heart, such as excitation-contraction coupling, 9 and fight or flight automaticity in sinoatrial nodal pacemaker cells. 10 However, excessive CaMKII also contributes to the major diseases of myocardium: arrhythmias and heart failure, leading our group to consider CaMKII as a candidate therapeutic target for heart disease. 11
Connecting Cellular Ca 2؉ With Membrane Excitability
CaMKII can modulate membrane excitability by direct effects on Na ϩ current (I Na ) and via indirect effects on the Na ϩ /Ca 2ϩ exchanger (NCX). I Na is mostly carried by Na V 1.5 in cardiomyocytes, and CaMKII slows I Na inactivation to prominently increase a small but important persistent or slow inactivating component of I Na . 12 CaMKII effects on Na V 1.5 produce a I Na phenocopy of a rare genetic arrhythmia syndrome (long QT syndrome 3) 13 and of the increased persistent component of I Na seen in heart failure. 14 CaMKII activity is increased in heart failure, 15 and an emerging body of evidence supports a view that Na V 1.5 is an important pathological target that contributes to excessive action potential duration, arrhythmia-initiating afterdepolarizations, and subsarcolemmal Na ϩ loading that reduces the efficiency of the NCX for exporting cellular Ca 2ϩ to the extracellular space. 16 Whereas I Na is required for normal membrane excitability in the atrial and ventricular myocardium, NCX current is associated with pathological automaticity in these cells. 17, 18 However, the NCX current is now recognized to play an important physiological role in membrane excitability in cardiac pacemaker cells, 19 many of which lack I Na . Thus, CaMKII is important for augmenting physiological and arrhythmogenic membrane excitability. defined localization profiles are an important mechanism for constraining signaling pathways and ensuring specificity. One common theme is for protein kinases to pair with phosphatases by adapter proteins that bring the kinase/ phosphatase module to the immediate vicinity of target proteins. We see ultrastructural evidence that CaMKII is targeted to specific microdomains in cardiac myocytes, 5 and the work of El-Haou et al shows that SAP97 can direct CaMKII signaling in atrial myocytes. In many cases, serine threonine kinases capable of regulating ion channels accomplish localization goals through specialized adapter proteins. In contrast, CaMKII seems not to have committed to a single localization strategy. CaMKII uses diverse approaches, including binding to sequences mimicking the autoinhibitory region of CaMKII itself. The CaMKII autoinhibitory domain is a pseudosubstrate for the catalytic domain and so sequences resembling the autoinhibitory domain have the potential to inhibit 20 or anchor 21 CaMKII by binding the catalytic domain.
The Ca V 1.2 and Ca V 1.3 ␤ subunits are MAGUK 22 proteins like SAP97. There are 4 main ␤ subunit genes, and each of these can encode a protein containing a conserved CaMKII phosphorylation site. 23 This CaMKII phosphorylation site (Thr498 on ␤ 2a ) is embedded within a primary sequence that is homologous to the CaMKII autoinhibitory domain in ␤ 1b and ␤ 2a . ␤ 1b and ␤ 2a bind CaMKII using these sequences. In fact, the position of Thr498 on ␤ 1b and ␤ 2a mirrors the relationship of the autophosphorylated Thr298 in the CaMKII autoinhibitory domain (Figure, A) . CaMKII phosphorylation of Thr498 appears to be necessary for CaMKII effects on Ca V 1.2 pore-forming ␣ subunits. 21 Interestingly, CaMKII binding to Ca V 1 ␤ subunits is dynamically regulated by Thr498 phosphorylation and by Thr286/287 autophosphorylation. Only autophosphorylated CaMKII binds the Ca V 1 ␤ subunits, whereas phosphorylation of Thr498 on the ␤ subunit markedly disables CaMKII binding. 23 The relationship between Ca V 1.2 activating features of ␤ subunit phosphorylation at Thr498 and the inhibitory consequences of this phosphorylation for CaMKII-␤ subunit binding suggest a homeostatic mechanism for limiting CaMKII-mediated increases in I Ca . It will be important for future studies to determine the molecular mechanism for CaMKII binding to K V channels to better understand the physiological role of CaMKII in modulating K V channels.
Is CaMKII a Multifunctional ␤ Subunit?
Ion channels exist as macromolecular protein complexes. The ␣ subunits build the channel pore, whereas ␤ subunits act on the pore to influence gating, expression, and assembly of ␣ subunits. We now know that CaMKII is frequently counted among ion channel macromolecular protein complexes, raising the question of whether we should consider CaMKII to be a multifunctional ion channel ␤ subunit. CaMKII performs a wide array of tasks that affect gating, expression, and perhaps intersubunit association. 24 Thus, CaMKII is multifunctional based on its repertoire of downstream functions. CaMKII responds to catecholamines 20 and angiotensin II 2 and so provides an important connection between key upstream ligands, membrane excitability, and repolarization. CaMKII has "sticky fingers" that connect a wide range of ion channels to the regulatory influence of Ca 2ϩ and reactive oxygen species.
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